CD163 and neoplasm: Heatmaps show enrichment scores (NES) of GO pathways in primary tumors (Figure 3B) and LN metastases (Figure 3C) according to NE-low and NE-high phenotype (Figure 3A), CD68+, CD163+, CD33+ cellular densities and MHCII-expression in tumor cells (in brief: macrophage-related parameters).